Biocon Gets Nod To Use CytoSorb For Critical COVID-19 Patients

Biocon gets approval for emergency use of CytoSorb to treat critical COVID-19 Patients. Biocon chairperson Kiran-Mazumdar Shaw shares the details of the device.

Related Videos